Anixa Biosciences
ANIX
18 hedge funds and large institutions have $2.22M invested in Anixa Biosciences in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
265% more capital inflows, than outflows
Capital inflows: $1.2M | Capital outflows: $329K
1.69% more ownership
Funds ownership: 4.01% → 5.7% (+1.7%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
10% less funds holding
Funds holding: 20 → 18 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$929K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$138K |
| 3 |
Bank of New York Mellon
New York
|
+$117K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$11.9K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
-$162K |
| 2 |
Two Sigma Securities
New York
|
-$117K |
| 3 |
Wedbush Securities
Los Angeles,
California
|
-$34K |
| 4 |
Concorde Asset Management
Ann Arbor,
Michigan
|
-$5.19K |
| 5 |
Morgan Stanley
New York
|
-$5.07K |
ANIX Hedge Fund Activity: Q4 2017 in Review
18 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q4 2017, worth a combined $2.22M — up 39% from $1.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ANIX and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $929K. The largest seller was Virtu Financial, exiting entirely with an estimated $162K sold.
- 18 institutional investors held Anixa Biosciences (ANIX) as of Q4 2017, down from 20 in Q3 2017.
- Funds reported $2.22M of Anixa Biosciences stock for Q4 2017, up 39% quarter-over-quarter.
- 3 funds opened new Anixa Biosciences positions in Q4 2017 and 5 closed out, a net change of -2 holders.
- The largest Anixa Biosciences buyer in Q4 2017 was Vanguard Group, an estimated $929K added.
- The largest Anixa Biosciences seller in Q4 2017 was Virtu Financial, an estimated $162K sold.
Based on aggregated 13F filings for Q4 2017.